GRIFOLS ITALY operating for over 15 years in the distribution of plasma-derived products in our country, having already achieved a leading position in the Italian market.
Ethics and quality of service are the main theme of our business in Italy and in the world, since 1940 in the service of health workers and patients users of our drugs.
Our mission is to bring to Italy all Proteins Plasma derivatives produced in large and modern plants of Parets (Spain) and Los Angeles (USA) and in new plants that will soon be added, with continual improvements in yield, purity and safety and introducing those innovative, currently under research and development.
The Group Grifols collects high quality human plasma through its FDA Approved US centers plasmapheresis .
We provide the Hospital Pharmacies systems for the distribution and monitoring of drugs (Kardex), modular cleanrooms (Misterium®), equipment for the preparation of sterile infusion solutions and products for oncology (Gri-fill® 3.0) and equipment single-dose packaging of drugs destined, in hospital administration, at the bedside (Blispack).
We provide blood and plasma centers bags and equipment for transfusion, the MB-VIP service (methylene Blue Virus Inactivated Plasma) and Advanced technologies for inactivation of pathogens (viruses and bacteria) of platelet concentrates as exclusive distributors for Italy Cerus Intercept technology Inc. This technology provides the advantage to the Italian transfusion centers can also be used for virusinattivazione “in house” Plasma distributed transfusion purposes. In addition we provide medicine Transfusion Italian simple systems and efficient traceability of the transfusion of blood and plasma (Gricode®) with the benefit cost / benefit truly competitive
Francesco Carugi, Managing Director at Grifols Italy, discusses the company’s presence in the plasma, plasma products and plasma diagnostics segments, the impact of the liberalization of the Italian plasma market on…
Finderm is the result of a courageous entrepreneurial experience, since you initiated the operations in 1995, in the most challenging times for the Italian pharmaceutical industry. Could you briefly introduce…
Molteni was created in 1892 and progressively developed a strong manufacturing base, a very active R&D department and a growing international presence. Could you introduce the story behind such achievements?…
You declared in a recent interview that Zambon Group will always keep complying with the vision of your father Alberto, who has always refused acquisition offers from multinationals- a striking…
You are specialised in Cardiology at Padua University, in Tropical Medicine and Hygiene at London University and in Pharmacology at Modena University, in Communication at Bocconi University in Milan, and…
Ferlito Farmaceutici was established in 1937 and has since then grown to become one of the most renowned pharmaceutical pre-wholesalers in Italy. Which specific values of Ferlito do you think…
After 67 years in the pharmaceutical industry, of which 45 at the head of Menarini, what would you say have been your personal keys to success? Most of my life,…
Italians are often praised to make up deficiencies of the country at national level with more creativity at a regional level- which is why Science Parks are coordinated at the…
Recordati was created in 1926, and the combined work of three generations turned the small laboratory not only into a local success story but also a broad European Group. Your…
Roche Italy is one of the companies which went through the most significant re-organization process in the country in the past three years- with important changes in both its marketing…
When you were appointed General Director of the Agenzia Italiana del Farmaco (AIFA) in 2007, the dedicated Investigation Commission highlighted the need for an in-depth reorganization of the Agency in…
When you became President of Sankyo Pharma Italy in 2003 one of your objectives was to maximize sales of the existing portfolio- and the company’s sales have impressively tripled in…
Intermediate distribution plays a crucial role in establishing bridges between industrial production and final delivery to patients- and in Italy, this function is executed with highly contained costs and commercial…